Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2010
09/16/2010US20100234394 Substituted benzimidazoles and methods of their use
09/16/2010US20100234391 N-substituted piperazines
09/16/2010US20100234390 Novel compound and their use
09/16/2010US20100234386 Quinoxaline derivatives as pi3 kinase inhibitors
09/16/2010US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
09/16/2010US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
09/16/2010US20100234369 5-cyanothienopyridines for the treatment of tumours
09/16/2010US20100234356 Compounds useful as chemokine receptor antagonists
09/16/2010US20100234355 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
09/16/2010US20100234354 Pyridazinone derivatives
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
09/16/2010US20100234340 Substituted Spiroamide Compounds
09/16/2010US20100233537 Triazine Containing Electrode Materials for Secondary Batteries
09/16/2010US20100233190 Targeted polymeric prodrugs containing multifunctional linkers
09/16/2010US20100233122 Novel benzimidazole derivatives
09/16/2010US20100233120 Hepatitis C Virus Inhibitors
09/16/2010US20100233106 Small-molecule modulators of melanin expression
09/16/2010CA2754998A1 Substituted nicotinamides as kcnq2/3 modulators
09/16/2010CA2754946A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754941A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754936A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754781A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754709A1 Compounds for the treatment of metabolic disorders
09/16/2010CA2754688A1 Novel isoindolin-1-one derivative
09/16/2010CA2754685A1 Substituted indazole amides
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/15/2010EP2228369A1 Pyrazole derivatives as protein kinase modulators
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2227770A2 Prolyl hydroxylase inhibitors
09/15/2010EP2227463A1 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/15/2010EP2227461A1 New compounds iii
09/15/2010EP2227460A1 Therapeutic oxy-phenyl-aryl compounds and their use
09/15/2010EP2227456A2 Hedgehog pathway antagonists and therapeutic applications thereof
09/15/2010EP2227452A2 Pyridine compounds
09/15/2010EP1910314B1 Benzimidazole derivatives for treatment of inflammatory diseases
09/15/2010EP1899301B1 Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/15/2010EP1833815B1 A process for preparation of imatinib base
09/15/2010EP1569908B1 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
09/15/2010CN101835773A Novel imidazole derivatives
09/15/2010CN101835772A Novel imidazole derivatives
09/15/2010CN101835760A Arylindenopyrimidines and their use as adenosine A2a receptor antagonists
09/15/2010CN101835758A Halosubstituted aryloxyalkylimidazolines for use as pesticides
09/15/2010CN101835757A Diacylglycerol acyltransferase inhibitors
09/15/2010CN101835756A 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
09/15/2010CN101835755A Novel kinase inhibitors
09/15/2010CN101835752A Heterocyclic amides useful for the treatment of cancer and psoriasis
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830888A Synthetic method of high-content nicosulfiaron
09/14/2010US7795471 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates
09/14/2010US7795447 4-(Acylaminoacetylamino)imidazole derivatives, e.g., methyl 3-(4-{2-[2-(3,5-Difluorophenyl)acetylamino]pentanoylamino}imidazol-1-yl)butyrate; treating neurodegenerative and/or neurological disorders such as Alzheimer's disease and Down's Syndrome
09/14/2010US7795440 N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
09/14/2010US7795439 In-situ treatment of pyridine 2,3-dicarboxylic acid esters with an oxidizing agent
09/14/2010US7795437 Ether derivatives
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795281 (R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester; calcium antagonistic action, antihypertensive action, vascular dilatory action, cardiac protective action, anti-arteriosclerotic action, diuretic action
09/14/2010US7795280 3-(2-Nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indole-6-carbonitrile, used for the treatment of benign prostate hyperplasia, bone disorders, female sexual dysfunction,, atherosclerosis, anemia, muscular atrophy, as contraceptives or for hormone replacement therapy
09/14/2010US7795278 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof
09/14/2010US7795277 7-(2-(4-(3-trifuloromethyl-phenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isoquinoline besylate salt, preparation and therapeutic use thereof
09/14/2010US7795271 Substituted pyrimidinones
09/14/2010US7795264 Tyrosine kinase with immunoglobulin and epidermal growth factor homology domain signaling inhibitors; dysregulated vascular growth disorders
09/14/2010US7795261 substance P receptor blockers, such as [2R-trans]-{2-benzyl-4-[4-(1-pyrazin-2-yl-pyrrolidin-3-yl)-piperazin-1-yl]-piperidin-1-yl}-(3,5-bis-trifluoromethyl-phenyl)-methanone, used for treating schizophrenia, emesis, anxiety and depression, irritable bowel syndrome, sleep disorders, pain and inflammation
09/14/2010US7795257 Organic compounds
09/14/2010US7795250 Indole derivatives as antiviral agents
09/14/2010US7795249 Certain pyrazoline derivatives with kinase inhibitory activity
09/14/2010US7795179 Substituted azole compounds and its preparation and use thereof
09/14/2010CA2601600C Substituted aryl 1,4-pyrazine derivatives
09/14/2010CA2441501C Rho-kinase inhibitors
09/14/2010CA2394276C Serine protease inhibitors
09/14/2010CA2393720C Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
09/14/2010CA2354210C Indole derivatives and their use as medicaments
09/10/2010WO2010101973A1 Fungicidal pyrazoles
09/10/2010WO2010101949A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010WO2010101849A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/10/2010WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism
09/10/2010WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
09/10/2010WO2010101164A1 Pyridine derivative
09/10/2010WO2010101128A1 Amide compound
09/10/2010WO2010101127A1 Indole compound
09/10/2010WO2010100876A1 Tetrazoyl oxime derivative, salt thereof, and plant disease control agent
09/10/2010WO2010100606A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
09/10/2010WO2010100476A2 Improved process
09/10/2010WO2010100475A1 Hydroxamic acid derivatives as gram-negative antibacterial agents
09/10/2010WO2010100405A1 Triazine derivatives as kinase inhibitors
09/10/2010WO2010100189A1 3-arylquinazolin-4-one compounds for combating invertebrate pests
09/10/2010WO2010100178A1 Heterocyclic antiviral compounds
09/10/2010WO2010100127A1 Disubstituted imidazole derivatives as modulators of raf kinase
09/10/2010WO2010100070A1 Inhibitors of bruton's tyrosine kinase
09/10/2010WO2010100050A1 Pyridine-2-yl-carboxylic acid amides
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors
09/10/2010WO2010018555A4 Quinoline compounds containing a dibemethin group
09/10/2010WO2009118765A8 Novel monoamine re-uptake inhibitor
09/10/2010WO2009116067A3 Novel derivatives of acyl cyanopyrrolidines
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010CA2753552A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/10/2010CA2753341A1 Inhibitors of bruton's tyrosine kinase
09/10/2010CA2753241A1 Process for the preparation of lenalidomide
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 1080